166 related articles for article (PubMed ID: 20713527)
21. A single factor induces neuronal differentiation to suppress glioma cell growth.
Fu JQ; Chen Z; Hu YJ; Fan ZH; Guo ZX; Liang JY; Ryu BM; Ren JL; Shi XJ; Li J; Jia S; Wang J; Ke XS; Ma X; Tan X; Zhang T; Chen XZ; Zhang C
CNS Neurosci Ther; 2019 Apr; 25(4):486-495. PubMed ID: 30264483
[TBL] [Abstract][Full Text] [Related]
22. HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance.
Loria R; Laquintana V; Bon G; Trisciuoglio D; Frapolli R; Covello R; Amoreo CA; Ferraresi V; Zoccali C; Novello M; Del Bufalo D; Milella M; Biagini R; D'Incalci M; Falcioni R
Oncogene; 2018 Nov; 37(45):5926-5938. PubMed ID: 29980789
[TBL] [Abstract][Full Text] [Related]
23. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
25. Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence.
Zhang S; Yan L; Cui C; Wang Z; Wu J; Zhao M; Dong B; Guan X; Tian X; Hao C
Oncol Rep; 2020 Aug; 44(2):565-576. PubMed ID: 32627015
[TBL] [Abstract][Full Text] [Related]
26. Silencing of perilipin by short hairpin RNA inhibits proliferation and induces apoptosis in liposarcoma cells.
Meng LX; Zheng YX; He ML; Zhou XM; Sun SY; Ding ZJ; Meng Q; Li BC; Sun YW
Mol Med Rep; 2018 Nov; 18(5):4571-4576. PubMed ID: 30221658
[TBL] [Abstract][Full Text] [Related]
27. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
28. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
29. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
30. Application of molecular biology to individualize therapy for patients with liposarcoma.
Abbas Manji G; Singer S; Koff A; Schwartz GK
Am Soc Clin Oncol Educ Book; 2015; ():213-8. PubMed ID: 25993159
[TBL] [Abstract][Full Text] [Related]
31. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
[TBL] [Abstract][Full Text] [Related]
32. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.
Zhang YX; Sicinska E; Czaplinski JT; Remillard SP; Moss S; Wang Y; Brain C; Loo A; Snyder EL; Demetri GD; Kim S; Kung AL; Wagner AJ
Mol Cancer Ther; 2014 Sep; 13(9):2184-93. PubMed ID: 25028469
[TBL] [Abstract][Full Text] [Related]
34. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
[TBL] [Abstract][Full Text] [Related]
35. miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling.
Mazzu YZ; Hu Y; Shen Y; Tuschl T; Singer S
Sci Rep; 2019 Mar; 9(1):3197. PubMed ID: 30824765
[TBL] [Abstract][Full Text] [Related]
36. Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6.
Guan M; Fousek K; Jiang C; Guo S; Synold T; Xi B; Shih CC; Chow WA
Clin Cancer Res; 2011 Apr; 17(7):1796-806. PubMed ID: 21355074
[TBL] [Abstract][Full Text] [Related]
37. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.
Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I
Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553
[TBL] [Abstract][Full Text] [Related]
38. ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a.
Qiang W; Zhao Y; Yang Q; Liu W; Guan H; Lv S; Ji M; Shi B; Hou P
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1163-72. PubMed ID: 24684457
[TBL] [Abstract][Full Text] [Related]
39. Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma.
Li C; Shen Y; Ren Y; Liu W; Li M; Liang W; Liu C; Li F
Hum Pathol; 2016 Sep; 55():143-50. PubMed ID: 27237367
[TBL] [Abstract][Full Text] [Related]
40. [Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].
Lanckohr C; Kasprzynski A; Klein-Hitpass L; Homann HH; Lehnhardt M; Müller O; Kuhnen C; Herter P
Pathologe; 2010 Feb; 31(1):60-6. PubMed ID: 19823827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
